Your browser doesn't support javascript.
loading
Virtual exploration of early stage atherosclerosis.
Olivares, Andy L; González Ballester, Miguel A; Noailly, Jérôme.
Afiliação
  • Olivares AL; Institute for Bioengineering of Catalonia (IBEC), 08028 Barcelona, Spain.
  • González Ballester MA; Department of Information and Communication Technologies (DTIC), Universitat Pompeu Fabra (UPF), 08018 Barcelona, Spain.
  • Noailly J; Department of Information and Communication Technologies (DTIC), Universitat Pompeu Fabra (UPF), 08018 Barcelona, Spain.
Bioinformatics ; 32(24): 3798-3806, 2016 12 15.
Article em En | MEDLINE | ID: mdl-27578803
MOTIVATION: Biological mechanisms contributing to atherogenesis are multiple and complex. The early stage of atherosclerosis (AS) is characterized by the accumulation of low-density lipoprotein (LDL) droplets, leading to the creation of foam cells (FC). To address the difficulty to explore the dynamics of interactions that controls this process, this study aimed to develop a model of agents and infer on the most influential cell- and molecule-related parameters. RESULTS: FC started to accumulate after six to eight months of simulated hypercholesterolemia. A sensitivity analysis revealed the strong influence of LDL oxidation rate on the risk of FC creation, which was exploited to model the antioxidant effect of statins. Combined with an empirical simulation of the drug ability to decrease the level of LDL, the virtual statins treatment led to reductions of oxidized LDL levels similar to reductions measured in vivo. AVAILABILITY AND IMPLEMENTATION: An Open source software was used to develop the agent-based model of early AS. Two different concentrations of LDL agents were imposed in the intima layer to simulate healthy and hypercholesterolemia groups of 'virtual patients'. The interactions programmed between molecules and cells were based on experiments and models reported in the literature. A factorial sensitivity analysis explored the respective effects of the less documented model parameters as (i) agent migration speed, (ii) LDL oxidation rate and (iii) concentration of autoantibody agents. Finally, the response of the model to known perturbations was assessed by introducing statins agents, able to reduce the oxidation rate of LDL agents and the LDL boundary concentrations. CONTACT: jerome.noailly@upf.eduSupplementary information: Supplementary data are available at Bioinformatics online.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aterosclerose / Hipercolesterolemia / Lipoproteínas LDL Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aterosclerose / Hipercolesterolemia / Lipoproteínas LDL Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article